Freedom Broker analyst Georgy Vashchenko initiated coverage of Lifeway Foods with a Buy rating and $34 price target. Lifeway is a dairy company specializing in probiotic, fermented food and beverage products, primarily kefir, distributed across retail channels nationwide, the analyst tells investors in a research note. The firm says the company is well positioned to benefit from increasing consumer focus on gut health, protein intake, and functional nutrition.
